JP2019520332A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520332A5
JP2019520332A5 JP2018561467A JP2018561467A JP2019520332A5 JP 2019520332 A5 JP2019520332 A5 JP 2019520332A5 JP 2018561467 A JP2018561467 A JP 2018561467A JP 2018561467 A JP2018561467 A JP 2018561467A JP 2019520332 A5 JP2019520332 A5 JP 2019520332A5
Authority
JP
Japan
Prior art keywords
cells
peptide
cmv
apc
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018561467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520332A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/000849 external-priority patent/WO2017203370A2/en
Publication of JP2019520332A publication Critical patent/JP2019520332A/ja
Publication of JP2019520332A5 publication Critical patent/JP2019520332A5/ja
Priority to JP2023020200A priority Critical patent/JP2023071724A/ja
Pending legal-status Critical Current

Links

JP2018561467A 2016-05-23 2017-05-23 Ｃｍｖエピトープ Pending JP2019520332A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023020200A JP2023071724A (ja) 2016-05-23 2023-02-13 Ｃｍｖエピトープ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662340223P 2016-05-23 2016-05-23
US62/340,223 2016-05-23
PCT/IB2017/000849 WO2017203370A2 (en) 2016-05-23 2017-05-23 Cmv epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023020200A Division JP2023071724A (ja) 2016-05-23 2023-02-13 Ｃｍｖエピトープ

Publications (2)

Publication Number Publication Date
JP2019520332A JP2019520332A (ja) 2019-07-18
JP2019520332A5 true JP2019520332A5 (enExample) 2020-07-02

Family

ID=60412168

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018561467A Pending JP2019520332A (ja) 2016-05-23 2017-05-23 Ｃｍｖエピトープ
JP2023020200A Pending JP2023071724A (ja) 2016-05-23 2023-02-13 Ｃｍｖエピトープ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023020200A Pending JP2023071724A (ja) 2016-05-23 2023-02-13 Ｃｍｖエピトープ

Country Status (7)

Country Link
US (2) US20200316119A1 (enExample)
EP (1) EP3463400A4 (enExample)
JP (2) JP2019520332A (enExample)
CN (1) CN109475579A (enExample)
AU (3) AU2017271136A1 (enExample)
CA (1) CA3025234A1 (enExample)
WO (1) WO2017203370A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS
CA3100420A1 (en) * 2018-05-18 2019-11-21 The Council Of The Queensland Institute Of Medical Research Adoptive t-cell therapy for cmv infection and cmv-associated diseases
MX2021002702A (es) 2018-09-10 2021-05-12 Atara Biotherapeutics Inc Metodos para expandir celulas t del receptor de antigeno quimerico especificas de antigenos, composiciones y usos relacionados con las mismas.
US20260055195A1 (en) * 2019-10-09 2026-02-26 The Council Of The Queensland Institute Of Medical Research Targeting epha3 and uses thereof
BR112022021769A2 (pt) * 2020-04-28 2022-12-13 Council Queensland Inst Medical Res Composição de vacina de poliepítopo de citomegalovírus humano
CN111875698B (zh) * 2020-07-29 2021-11-05 广州呈源生物免疫技术有限公司 靶向hcmv的tcr及其获得方法和应用
KR102769935B1 (ko) * 2021-03-30 2025-02-19 한국과학기술원 펩타이드-mhc에 대한 t 세포 활성의 예측 방법 및 분석장치

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041442B1 (en) * 1999-06-04 2006-05-09 Florian Kern Peptides for vaccinating against human CMV
DE10009341A1 (de) * 2000-02-22 2001-09-06 Florian Kern Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
PT1651666E (pt) * 2003-07-11 2009-08-28 Alphavax Inc Vacinas de citomegalovírus à base de alfavírus
AU2012227280B2 (en) * 2004-11-29 2016-09-22 The Council Of The Queensland Institute Of Medical Research Human cytomegalovirus immunotherapy
WO2006056027A1 (en) * 2004-11-29 2006-06-01 The Council Of The Queensland Institute Of Medical Research Human cytomegalovirus immunotherapy
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same
US20110136896A1 (en) * 2008-08-01 2011-06-09 Tong-Ming Fu Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof
WO2010037397A1 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cmv immune monitoring
GB0917094D0 (en) * 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
EP2812431B1 (en) * 2012-02-09 2019-07-17 Baylor College Of Medicine Pepmixes to generate multiviral ctls with broad specificity
WO2013170305A1 (en) * 2012-05-16 2013-11-21 Adelaide Research & Innovation Pty Ltd Cellular vaccine and method of inducing an immune response in a subject
GB201312133D0 (en) * 2013-07-05 2013-08-21 Univ Birmingham Immunotherapy
US9757446B2 (en) * 2014-03-17 2017-09-12 Flugen, Inc. Influenza virus vectors and uses therefor

Similar Documents

Publication Publication Date Title
JP6612963B2 (ja) 腫瘍抗原を直接認識するために組換えｔ細胞レセプターを使用するための組成物及び方法
TWI776160B (zh) 用於不同類型癌症免疫治療的非經典來源的肽和肽組合
TWI796299B (zh) 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
WO2022068850A1 (zh) Kras突变特异性t细胞受体筛选及抗肿瘤用途
Kim et al. Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T-and B-cell responses
TWI730306B (zh) 用於抗cll及其他癌症之免疫治療的新穎胜肽及胜肽組合物
CN108778291B (zh) 包含重组t细胞受体的组合物和文库以及使用重组t细胞受体的方法
TWI722663B (zh) 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架
TWI781104B (zh) 新型肽、肽組合物作為靶標以及用於膽囊癌、膽管癌和其他癌症免疫治療
TW201734039A (zh) 用於膀胱癌和其它癌症免疫治療的肽、肽組合物和基於細胞的藥物
TW201734036A (zh) 用於nhl和其他癌症免疫治療的新型肽和肽組合物
TW201726723A (zh) 用於對抗多種癌症的免疫療法的新胜肽及胜肽組合
CA3026180A1 (en) Human leukocyte antigen restricted gamma delta t cell receptors and methods of use thereof
TW201311895A (zh) 用於胰臟癌之樹突細胞（ｄｃ）－疫苗療法
IL309003A (en) Novel peptides, combination of peptides and scaffolds for use in immunothera-peutic treatment of various cancers
JP2019516768A5 (enExample)
US20190374627A1 (en) Target peptides for cancer therapy and diagnostics
TWI374031B (enExample)
TW202300510A (zh) 用於對抗多種癌症的免疫療法的新胜肽及胜肽組合
WO2016093243A9 (ja) 腫瘍抗原ペプチド
Bright et al. SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients
TW202140534A (zh) 個人化醫藥
JP2021511054A5 (enExample)
Wang et al. A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity
CN114853880A (zh) Wt1抗原特异性t细胞受体及其抗肿瘤用途